Skip to main content

Table 1 Description of the population of patients with breast cancer diagnosed between 2007 and 2012 in three French administrative areas

From: Trends in molecular subtypes of breast cancer: description of incidence rates between 2007 and 2012 from three French registries

Variable N = 12,040 %
Year   
 2007 1976 16.4
 2008 1940 16.1
 2009 1910 15.9
 2010 2069 17.2
 2011 2063 17.1
 2012 2082 17.3
Age class   
 < 40 547 4.5
 40–54 3447 28.6
 55–69 4377 36.4
 > = 70 3669 30.5
Biomarker   
 ER+ (699 NA, 6%) 9492 78.8
 PR+ (707 NA, 6%) 8144 67.6
 HER2+ (1524 NA, 13%) 1239 10.3
Molecular subtype   
 TN 1111 9.2
 HR+/HER2+ 758 6.3
 HR+/HER2- 8041 66.8
 HR-/HER2+ 447 3.7
 NA 1683 14.0
  1. ER: estrogen receptor, PR: progesterone receptor, HER2: human epidermal growth factor receptor, TN: triple negative; HR: hormonal receptor; NA: not available
\